Antibody and B cell responses to Plasmodium sporozoites

Frontiers in Microbiology

Volumn 5, Issue NOV, 2014, Pages

  Dups, Johanna N ^a   Pepper, Marion ^b   Cockburn, Ian A ^a  

^a Australian National University   (Australia)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Antibodies; B cells; Malaria; Plasmodium; Pre erythrocytic stages; Sporozoites

Indexed keywords

MALARIA VACCINE;

ANTIBODY RESPONSE; B LYMPHOCYTE; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FLOW CYTOMETRY; HUMAN; HUMORAL IMMUNITY; IMMUNIZATION; INFECTION CONTROL; MALARIA; MEMORY CELL; NONHUMAN; PHASE 3 CLINICAL TRIAL (TOPIC); PLASMODIUM; PLASMODIUM YOELII INFECTION; SHORT SURVEY; SPOROZOITE;

EID: 84987845540     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2014.00625     Document Type: Short Survey

References (76)

1. + T cells and memory B cells in Gabonese children vaccinated with RTS, S/AS01E and RTS, S/AS02D. PLoS ONE 6:e18559. doi: 10.1371/journal.pone.0018559
2. Agnandji, S. T., Lell, B., Soulanoudjingar, S. S., Fernandes, J. F., Abossolo, B. P., Conzelmann, C., et al. (2011b). First results of phase 3 trial of RTS, S/AS01 malaria vaccine in African children. N. Engl. J. Med. 365, 1863-1875. doi: 10.1056/NEJMoa1102287
3. Amino, R., Thiberge, S., Martin, B., Celli, S., Shorte, S., Frischknecht, F., et al. (2006). Quantitative imaging of Plasmodium transmission from mosquito to mammal. Nat. Med. 12, 220-224. doi: 10.1038/nm1350
4. Behet, M. C., Foquet, L., Van Gemert, G. J., Bijker, E. M., Meuleman, P., Leroux-Roels, G., et al. (2014). Sporozoite immunization of human volunteers under chemoprophylaxis induces functional antibodies against pre-erythrocytic stages of Plasmodium falciparum. Malar. J. 13, 136. doi: 10.1186/1475-2875-13-136
5. Bongfen, S. E., Ntsama, P. M., Offner, S., Smith, T., Felger, I., Tanner, M., et al. (2009). The N-terminal domain of Plasmodium falciparum circumsporozoite protein represents a target of protective immunity. Vaccine 27, 328-335. doi: 10.1016/j.vaccine.2008.09.097
6. Casares, S., Brumeanu, T. D., and Richie, T. L. (2010). The RTS, S malaria vaccine. Vaccine 28, 4880-4894. doi: 10.1016/j.vaccine.2010.05.033
7. Cerami, C., Frevert, U., Sinnis, P., Takacs, B., Clavijo, P., Santos, M. J., et al. (1992). The basolateral domain of the hepatocyte plasma membrane bears receptors for the circumsporozoite protein of Plasmodium falciparum sporozoites. Cell 70, 1021-1033. doi: 10.1016/0092-8674(92)90251-7
8. + T lymphocytes protective against malaria liver stages are primed in skin-draining lymph nodes. Nat. Med. 13, 1035-1041. doi: 10.1038/nm1628
9. Charoenvit, Y., Fallarme, V., Rogers, W. O., Sacci, J. B. Jr., Kaur, M., Aguiar, J. C., et al. (1997). Development of two monoclonal antibodies against Plasmodium falciparum sporozoite surface protein 2 and mapping of B-cell epitopes. Infect. Immun. 65, 3430-3437.
10. Chatterjee, S., Francois, G., Druilhe, P., Timperman, G., and Wery, M. (1996). Immunity to Plasmodium berghei exoerythrocytic forms derived from irradiated sporozoites. Parasitol. Res. 82, 297-303. doi: 10.1007/s004360050117
11. Clyde, D. F., Mccarthy, V. C., Miller, R. M., and Hornick, R. B. (1973). Specificity of protection of man immunized against sporozoite-induced falciparum malaria. Am. J. Med. Sci. 266, 398-403. doi: 10.1097/00000441-197312000-00001
12. Coppi, A., Natarajan, R., Pradel, G., Bennett, B. L., James, E. R., Roggero, M. A., et al. (2011). The malaria circumsporozoite protein has two functional domains, each with distinct roles as sporozoites journey from mosquito to mammalian host. J. Exp. Med. 208, 341-356. doi: 10.1084/jem.20101488
13. 4+ T cells but does not protect against experimental Plasmodium falciparum infection. Vaccine 28, 5135-5144. doi: 10.1016/j.vaccine.2009.08.046
14. Dame, J. B., Williams, J. L., Mccutchan, T. F., Weber, J. L., Wirtz, R. A., Hockmeyer, W. T., et al. (1984). Structure of the gene encoding the immunodominant surface antigen on the sporozoite of the human malaria parasite Plasmodium falciparum. Science 225, 593-599. doi: 10.1126/science.6204383
15. Domarle, O., Migot-Nabias, F., Mvoukani, J. L., Lu, C. Y., Nabias, R., Mayombo, J., et al. (1999). Factors influencing resistance to reinfection with Plasmodium falciparum. Am. J. Trop. Med. Hyg. 61, 926-931.
16. + T cells in the Plasmodium yoelii model. J. Immunol. 163, 884-892.
17. Duffy, P. E., Sahu, T., Akue, A., Milman, N., and Anderson, C. (2012). Pre-erythrocytic malaria vaccines: identifying the targets. Expert Rev. Vaccines 11, 1261-1280. doi: 10.1586/erv.12.92
18. Ellis, J., Ozaki, L. S., Gwadz, R. W., Cochrane, A. H., Nussenzweig, V., Nussenzweig, R. S., et al. (1983). Cloning and expression in E. coli of the malarial sporozoite surface antigen gene from Plasmodium knowlesi. Nature 302, 536-538. doi: 10.1038/302536a0
19. Enea, V., Arnot, D., Schmidt, E. C., Cochrane, A., Gwadz, R., and Nussenzweig, R. S. (1984). Circumsporozoite gene of Plasmodium cynomolgi (Gombak):cDNA cloning and expression of the repetitive circumsporozoite epitope. Proc. Natl. Acad. Sci. U.S.A. 81, 7520-7524. doi: 10.1073/pnas.81.23.7520
20. Felgner, P. L., Roestenberg, M., Liang, L., Hung, C., Jain, A., Pablo, J., et al. (2013). Pre-erythrocytic antibody profiles induced by controlled human malaria infections in healthy volunteers under chloroquine prophylaxis. Sci. Rep. 3, 3549. doi: 10.1038/srep03549
21. Fidock, D. A., Pasquetto, V., Gras, H., Badell, E., Eling, W., Ballou, W. R., et al. (1997). Plasmodium falciparum sporozoite invasion is inhibited by naturally acquired or experimentally induced polyclonal antibodies to the STARP antigen. Eur. J. Immunol. 27, 2502-2513. doi: 10.1002/eji.1830271007
22. Finney, O. C., Keitany, G. J., Smithers, H., Kaushansky, A., Kappe, S., and Wang, R. (2014). Immunization with genetically attenuated P. falciparum parasites induces long-lived antibodies that efficiently block hepatocyte invasion by sporozoites. Vaccine 32, 2135-2138. doi: 10.1016/j.vaccine.2014.02.055
23. Foquet, L., Hermsen, C. C., Van Gemert, G. J., Van Braeckel, E., Weening, K. E., Sauerwein, R., et al. (2014). Vaccine-induced monoclonal antibodies targeting circumsporozoite protein prevent Plasmodium falciparum infection. J. Clin. Invest. 124, 140-144. doi: 10.1172/JCI70349
24. Frevert, U., Sinnis, P., Cerami, C., Shreffler, W., Takacs, B., and Nussenzweig, V. (1993). Malaria circumsporozoite protein binds to heparan sulfate proteoglycans associated with the surface membrane of hepatocytes. J. Exp. Med. 177, 1287-1298. doi: 10.1084/jem.177.5.1287
25. Gruner, A. C., Mauduit, M., Tewari, R., Romero, J. F., Depinay, N., Kayibanda, M., et al. (2007). Sterile protection against malaria is independent of immune responses to the circumsporozoite protein. PLoS ONE 2:e1371. doi: 10.1371/journal.pone.0001371
26. Guinovart, C., Aponte, J. J., Sacarlal, J., Aide, P., Leach, A., Bassat, Q., et al. (2009). Insights into long-lasting protection induced by RTS, S/AS02A malaria vaccine: further results from a phase IIb trial in Mozambican children. PLoS ONE 4:e5165. doi: 10.1371/journal.pone.0005165
27. Hoffman, S. L., Goh, L. M., Luke, T. C., Schneider, I., Le, T. P., Doolan, D. L., et al. (2002). Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. J. Infect. Dis. 185, 1155-1164. doi: 10.1086/339409
28. Illingworth, J., Butler, N. S., Roetynck, S., Mwacharo, J., Pierce, S. K., Bejon, P., et al. (2013). Chronic exposure to Plasmodium falciparum is associated with phenotypic evidence of B and T cell exhaustion. J. Immunol. 190, 1038-1047. doi: 10.4049/jimmunol.1202438
29. John, C. C., Moormann, A. M., Pregibon, D. C., Sumba, P. O., Mchugh, M. M., Narum, D. L., et al. (2005). Correlation of high levels of antibodies to multiple pre-erythrocytic Plasmodium falciparum antigens and protection from infection. Am. J. Trop. Med. Hyg. 73, 222-228.
30. Kester, K. E., Cummings, J. F., Ofori-Anyinam, O., Ockenhouse, C. F., Krzych, U., Moris, P., et al. (2009). Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS, S/AS01B and RTS, S/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection. J. Infect. Dis. 200, 337-346. doi: 10.1086/600120
31. Kester, K. E., Gray Heppner, D. Jr., Moris, P., Ofori-Anyinam, O., Krzych, U., Tornieporth, N., et al. (2014). Sequential Phase 1 and Phase 2 randomized, controlled trials of the safety, immunogenicity and efficacy of combined pre-erythrocytic vaccine antigens RTS, S and TRAP formulated with AS02 Adjuvant System in healthy, malaria naive adults. Vaccine 32, 6683-6691. doi: 10.1016/j.vaccine.2014.06.033
32. Kester, K. E., Mckinney, D. A., Tornieporth, N., Ockenhouse, C. F., Heppner, D. G., Hall, T., et al. (2001). Efficacy of recombinant circumsporozoite protein vaccine regimens against experimental Plasmodium falciparum malaria. J. Infect. Dis. 183, 640-647. doi: 10.1086/318534
33. Liu, X. Q., Stacey, K. J., Horne-Debets, J. M., Cridland, J. A., Fischer, K., Narum, D., et al. (2012). Malaria infection alters the expression of B-cell activating factor resulting in diminished memory antibody responses and survival. Eur. J. Immunol. 42, 3291-3301. doi: 10.1002/eji.201242689
34. Mauduit, M., Gruner, A. C., Tewari, R., Depinay, N., Kayibanda, M., Chavatte, J. M., et al. (2009). A role for immune responses against non-CS components in the cross-species protection induced by immunization with irradiated malaria sporozoites. PLoS ONE 4:e7717. doi: 10.1371/journal.pone.0007717
35. Moir, S., Ho, J., Malaspina, A., Wang, W., Dipoto, A. C., O'Shea, M. A., et al. (2008). Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals. J. Exp. Med. 205, 1797-1805. doi: 10.1084/jem.20072683
36. Moorthy, V. S., and Ballou, W. R. (2009). Immunological mechanisms underlying protection mediated by RTS, S: a review of the available data. Malar. J. 8, 312. doi: 10.1186/1475-2875-8-312
37. Muellenbeck, M. F., Ueberheide, B., Amulic, B., Epp, A., Fenyo, D., Busse, C. E., et al. (2013). Atypical and classical memory B cells produce Plasmodium falciparum neutralizing antibodies. J. Exp. Med. 210, 389-399. doi: 10.1084/jem.20121970
38. Nahrendorf, W., Scholzen, A., Bijker, E. M., Teirlinck, A. C., Bastiaens, G. J., Schats, R., et al. (2014). Memory B-cell and antibody responses induced by Plasmodium falciparum sporozoite immunization. J. Infect. Dis. doi: 10.1093/infdis/jiu354 [Epub ahead of print].
39. Nardin, E. H., and Nussenzweig, R. S. (1993). T cell responses to pre-erythrocytic stages of malaria: role in protection and vaccine development against pre-erythrocytic stages. Annu. Rev. Immunol. 11, 687-727. doi: 10.1146/annurev.iy.11.040193.003351
40. Nardin, E. H., Nussenzweig, V., Nussenzweig, R. S., Collins, W. E., Harinasuta, K. T., Tapchaisri, P., et al. (1982). Circumsporozoite proteins of human malaria parasites Plasmodium falciparum and Plasmodium vivax. J. Exp. Med. 156, 20-30. doi: 10.1084/jem.156.1.20
41. Nduati, E., Gwela, A., Karanja, H., Mugyenyi, C., Langhorne, J., Marsh, K., et al. (2011). The plasma concentration of the B cell activating factor is increased in children with acute malaria. J. Infect. Dis. 204, 962-970. doi: 10.1093/infdis/jir438
42. Ng, D. H., Skehel, J. J., Kassiotis, G., and Langhorne, J. (2014). Recovery of an antiviral antibody response following attrition caused by unrelated infection. PLoS Pathog. 10:e1003843. doi: 10.1371/journal.ppat.1003843
43. Nguyen, T. V., Sacci, J. B. Jr., De La Vega, P., John, C. C., James, A. A., Kang, A. S., et al. (2009). Characterization of immunoglobulin G antibodies to Plasmodium falciparum sporozoite surface antigen MB2 in malaria exposed individuals. Malar. J. 8, 235. doi: 10.1186/1475-2875-8-235
44. Nussenzweig, R. S., Vanderberg, J., Most, H., and Orton, C. (1967). Protective immunity produced by the injection of x-irradiated sporozoites of Plasmodium berghei. Nature 216, 160-162. doi: 10.1038/216160a0
45. Nussenzweig, R. S., Vanderberg, J. P., Sanabria, Y., and Most, H. (1972). Plasmodium berghei: accelerated clearance of sporozoites from blood as part of immune-mechanism in mice. Exp. Parasitol. 31, 88-97. doi: 10.1016/0014-4894(72)90051-3
46. Ocana-Morgner, C., Mota, M. M., and Rodriguez, A. (2003). Malaria blood stage suppression of liver stage immunity by dendritic cells. J. Exp. Med. 197, 143-151. doi: 10.1084/jem.20021072
47. Offeddu, V., Thathy, V., Marsh, K., and Matuschewski, K. (2012). Naturally acquired immune responses against Plasmodium falciparum sporozoites and liver infection. Int. J. Parasitol. 42, 535-548. doi: 10.1016/j.ijpara.2012.03.011
48. Oliveira, G. A., Kumar, K. A., Calvo-Calle, J. M., Othoro, C., Altszuler, D., Nussenzweig, V., et al. (2008). Class II-restricted protective immunity induced by malaria sporozoites. Infect. Immun. 76, 1200-1206. doi: 10.1128/IAI.00566-07
49. Plassmeyer, M. L., Reiter, K., Shimp, R. L. Jr., Kotova, S., Smith, P. D., Hurt, D. E., et al. (2009). Structure of the Plasmodium falciparum circumsporozoite protein, a leading malaria vaccine candidate. J. Biol. Chem. 284, 26951-26963. doi: 10.1074/jbc.M109.013706
50. Plotkin, S. A. (2008). Vaccines: correlates of vaccine-induced immunity. Clin. Infect. Dis. 47, 401-409. doi: 10.1086/589862
51. Plotkin, S. A. (2010). Correlates of protection induced by vaccination. Clin. Vaccine Immunol. 17, 1055-1065. doi: 10.1128/CVI.00131-10
52. Portugal, S., Doumtabe, D., Traore, B., Miller, L. H., Troye-Blomberg, M., Doumbo, O. K., et al. (2012). B cell analysis of ethnic groups in Mali with differential susceptibility to malaria. Malar. J. 11, 162. doi: 10.1186/1475-2875-11-162
53. Potocnjak, P., Yoshida, N., Nussenzweig, R. S., and Nussenzweig, V. (1980). Monovalent fragments (Fab) of monoclonal antibodies to a sporozoite surface antigen (Pb44) protect mice against malarial infection. J. Exp. Med. 151, 1504-1513. doi: 10.1084/jem.151.6.1504
54. Rathore, D., Nagarkatti, R., Jani, D., Chattopadhyay, R., De La Vega, P., Kumar, S., et al. (2005). An immunologically cryptic epitope of Plasmodium falciparum circumsporozoite protein facilitates liver cell recognition and induces protective antibodies that block liver cell invasion. J. Biol. Chem. 280, 20524-20529. doi: 10.1074/jbc.M414254200
55. Roestenberg, M., Mccall, M., Hopman, J., Wiersma, J., Luty, A. J., Van Gemert, G. J., et al. (2009). Protection against a malaria challenge by sporozoite inoculation. N. Engl. J. Med. 361, 468-477. doi: 10.1056/NEJMoa0805832
56. Rts, S. C. T. P., Agnandji, S. T., Lell, B., Fernandes, J. F., Abossolo, B. P., Methogo, B. G., et al. (2012). A phase 3 trial of RTS, S/AS01 malaria vaccine in African infants. N. Engl. J. Med. 367, 2284-2295. doi: 10.1056/NEJMoa1208394
57. + T cells and antibodies required for immunity to malaria sporozoites. Nature 330, 664-666. doi: 10.1038/330664a0
58. Scholzen, A., Nahrendorf, W., Langhorne, J., and Sauerwein, R. W. (2014). Expansion of IgG+ B-cells during mitogen stimulation for memory B-cell ELISpot analysis is influenced by size and composition of the B-Cell pool. PLoS ONE 9:e102885. doi: 10.1371/journal.pone.0102885
59. Seder, R. A., Chang, L. J., Enama, M. E., Zephir, K. L., Sarwar, U. N., Gordon, I. J., et al. (2013). Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine. Science 341, 1359-1365. doi: 10.1126/science.1241800
60. Stoute, J. A., Slaoui, M., Heppner, D. G., Momin, P., Kester, K. E., Desmons, P., et al. (1997). A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS, S Malaria Vaccine Evaluation Group. N. Engl. J. Med. 336, 86-91. doi: 10.1056/NEJM199701093360202
61. Tam, J. P., Clavijo, P., Lu, Y. A., Nussenzweig, V., Nussenzweig, R., and Zavala, F. (1990). Incorporation of T and B epitopes of the circumsporozoite protein in a chemically defined synthetic vaccine against malaria. J. Exp. Med. 171, 299-306. doi: 10.1084/jem.171.1.299
62. Taylor, J. J., Jenkins, M. K., and Pape, K. A. (2012). Heterogeneity in the differentiation and function of memory B cells. Trends Immunol. 33, 590-597. doi: 10.1016/j.it.2012.07.005
63. Trieu, A., Kayala, M. A., Burk, C., Molina, D. M., Freilich, D. A., Richie, T. L., et al. (2011). Sterile protective immunity to malaria is associated with a panel of novel P. falciparum antigens. Mol. Cell. Proteomics 10, M111 007948. doi: 10.1074/mcp.M111.007948
64. Tsuji, M., Mombaerts, P., Lefrancois, L., Nussenzweig, R. S., Zavala, F., and Tonegawa, S. (1994). Gamma delta T cells contribute to immunity against the liver stages of malaria in alpha beta T-cell-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 91, 345-349. doi: 10.1073/pnas.91.1.345
65. Urban, B. C., Ferguson, D. J., Pain, A., Willcox, N., Plebanski, M., Austyn, J. M., et al. (1999). Plasmodium falciparum-infected erythrocytes modulate the maturation of dendritic cells. Nature 400, 73-77. doi: 10.1038/21900
66. Weiss, G. E., Clark, E. H., Li, S., Traore, B., Kayentao, K., Ongoiba, A., et al. (2011). A positive correlation between atypical memory B cells and Plasmodium falciparum transmission intensity in cross-sectional studies in Peru and Mali. PLoS ONE 6:e15983. doi: 10.1371/journal.pone.0015983
67. Weiss, G. E., Crompton, P. D., Li, S., Walsh, L. A., Moir, S., Traore, B., et al. (2009). Atypical memory B cells are greatly expanded in individuals living in a malaria-endemic area. J. Immunol. 183, 2176-2182. doi: 10.4049/jimmunol.0901297
68. + T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites. Proc. Natl. Acad. Sci. U.S.A. 85, 573-576. doi: 10.1073/pnas.85.2.573
69. White, M. T., Bejon, P., Olotu, A., Griffin, J. T., Bojang, K., Lusingu, J., et al. (2014). A combined analysis of immunogenicity, antibody kinetics and vaccine efficacy from phase 2 trials of the RTS, S malaria vaccine. BMC Med. 12:117. doi: 10.1186/s12916-014-0117-2
70. 4+ T cell responses and protection against Plasmodium falciparum infection. PLoS ONE 8:e61395. doi: 10.1371/journal.pone.0061395
71. Wipasa, J., Suphavilai, C., Okell, L. C., Cook, J., Corran, P. H., Thaikla, K., et al. (2010). Long-lived antibody and B Cell memory responses to the human malaria parasites, Plasmodium falciparum and Plasmodium vivax. PLoS Pathog. 6:e1000770. doi: 10.1371/journal.ppat.1000770
72. Wykes, M. N., Zhou, Y. H., Liu, X. Q., and Good, M. F. (2005). Plasmodium yoelii can ablate vaccine-induced long-term protection in mice. J. Immunol. 175, 2510-2516. doi: 10.4049/jimmunol.175.4.2510
73. Yoshida, N., Nussenzweig, R. S., Potocnjak, P., Nussenzweig, V., and Aikawa, M. (1980). Hybridoma produces protective antibodies directed against the sporozoite stage of malaria parasite. Science 207, 71-73. doi: 10.1126/science.6985745
74. Zavala, F., Cochrane, A. H., Nardin, E. H., Nussenzweig, R. S., and Nussenzweig, V. (1983). Circumsporozoite proteins of malaria parasites contain a single immunodominant region with two or more identical epitopes. J. Exp. Med. 157, 1947-1957. doi: 10.1084/jem.157.6.1947
75. Zavala, F., Tam, J. P., Hollingdale, M. R., Cochrane, A. H., Quakyi, I., Nussenzweig, R. S., et al. (1985). Rationale for development of a synthetic vaccine against Plasmodium falciparum malaria. Science 228, 1436-1440. doi: 10.1126/science.2409595
76. Zotos, D., and Tarlinton, D. M. (2012). Determining germinal centre B cell fate. Trends Immunol. 33, 281-288. doi: 10.1016/j.it.2012.04.003